Dr. Alex Spira, MD, PhD
Claim this profileNEXT Oncology
Expert in Solid Tumors
Studies Lung Cancer
21 reported clinical trials
32 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Alex Spira, MD, PhD is currently running
ARTS-021
for Advanced Cancer
This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients with advanced solid tumors. AVZO-021 is an oral medication that inhibits cyclin-dependent kinase 2 (CDK 2).
Recruiting1 award Phase 1 & 2
MCLA-129
for Non-Small Cell Lung Cancer
This trial tests a new drug, MCLA-129, on its own in patients with advanced cancers who did not respond to previous treatments. The study will adjust doses to find the safest and most effective amount.
Recruiting1 award Phase 1 & 217 criteria
More about Alex Spira, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Alex Spira, MD, PhD has experience with
- Nab-paclitaxel
- Pembrolizumab
- H002
- Nivolumab
- BBP-398
- Botensilimab
Breakdown of trials Alex Spira, MD, PhD has run
Lung Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex Spira, MD, PhD specialize in?
Alex Spira, MD, PhD focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Alex Spira, MD, PhD currently recruiting for clinical trials?
Yes, Alex Spira, MD, PhD is currently recruiting for 7 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Alex Spira, MD, PhD has studied deeply?
Yes, Alex Spira, MD, PhD has studied treatments such as Nab-paclitaxel, Pembrolizumab, H002.
What is the best way to schedule an appointment with Alex Spira, MD, PhD?
Apply for one of the trials that Alex Spira, MD, PhD is conducting.
What is the office address of Alex Spira, MD, PhD?
The office of Alex Spira, MD, PhD is located at: NEXT Oncology, Fairfax, Virginia 22031 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.